Auf dieser Seite
01STE Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
26Meine Kennzahlen
STE STERIS plc (Ireland) Ordinary Shares
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 7, 2026
$208,54
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$195,1452-Wochen-Tief
$269,4452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$20.33B
P/E
26.3
EPS
$7.93
Umsatz
$5.94B
Ihre Abzeichen
52W-Spanne
$195–$269
Analystenbewertung
BUY
Kursziel
$263
P/E
26.3
ROE
11.3%
Nettogewinnmarge
13.3%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
STE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$208.54
Marktkapitalisierung (MRQ)
$20.33B
P/E
26.3
EPS
$7.93
Umsatz
$5.94B
Dividendenrendite
1.2%
ROE
11.3%
Verschuldungsgrad (MRQ)
0.3
52W-Spanne
$195–$269
STE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 25. August 1998 | 2-for-1 | Vorwärts |
| 25. August 1995 | 2-for-1 | Vorwärts |
Über STERIS plc (Ireland) Ordinary Shares Unternehmensübersicht von Wikipedia
Die STERIS plc ist ein britisches Unternehmen für Sterilisation, Infektionsprävention, Desinfektion und Dekontamination mit Sitz in Derby und operativer Hauptzentrale in Mentor im US-Bundesstaat Ohio. Hauptabnehmer sind Krankenhäuser, wissenschaftliche Forschungseinrichtungen und Unternehmen der Pharmaindustrie.
Die Aktien des Unternehmens werden an der New York Stock Exchange gehandelt.
## Geschichte
Das Unternehmen wurde 1985 als Innovative Medical Technologies gegründet und 1987 in Steris Corporation umbenannt. Zu dieser Zeit beschäftigte das Unternehmen fünf Mitarbeiter. Die Wurzeln des Unternehmens reichen jedoch bis zur 1894 gegründeten American Sterilizer Company.
1992 folgte der Börsengang an der NASDAQ, 1998 wechselte man zur New York Stock Exchange.
Die Geschichte von Steris ist vor allem durch Firmenübernahmen geprägt. Im Jahr 1996 übernahm Steris die Marke Amsco sowie die Unternehmen Surgicot, und Calgon Vestal Laboratories, 1997 Isomedix Services und Joslyn Sterilizer Corporation, 1998 dann Detach, Hausted und Royal Sterilization Systems sowie 1999 Quality Sterilization Services und FoodLabs. Mit der Übernahme von US Endoscopy, der Spectrum Surgical Instrument Corporation und Total
Repair Express war die Mitarbeiterzahl von Steris im Jahr 2012 bereits auf 5.000 Menschen in 60 Ländern angewachsen.
Im Jahr 2014 übernahm Steris die Integrated Medical Systems International, Eschmann Equipment, Florida Surgical Repair und Life Systems.
Im Oktober 2014 kündigte Steris an, seinen britischen Konkurrenten Synergy Health für 1,9 Milliarden US-Dollar zu übernehmen und seinen Sitz in das Vereinigte Königreich zu verlegen. Durch die Fusion wird ein Unternehmen mit weltweit 14.000 Mitarbeitern und einem Jahresumsatz von 2,6 Milliarden US-Dollar entstehen. Am 28. Mai 2015 stoppte die US-Aufsichtsbehörde FTC die Übernahme. Steris ging erfolgreich dagegen vor und verkündete am 24. September 2015, mit der Fusion fortzufahren. Am 2. November 2015 schloss Steris die Übernahme und die Sitzverlegung ins Vereinigte Königreich ab.
Im November 2018 gab Steris bekannt seinen Sitz vom Vereinigten Königreich nach Irland zu verlegen. Gründe sind der Brexit und niedrigere Steuern in Irland.
Im Juni 2021 wurde Cantel Medical Corporation übernommen.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter17.937
LandIE
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$5.94B2017-03-31 → 2026-03-31
EPS$7.932017-03-31 → 2026-03-31
Freier Cashflow$972M2019-03-31 → 2026-03-31
Nettogewinnmarge13.3%2019-03-31 → 2026-03-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | STE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | 26.35-Jahres-Durchschnitt ≈79.9 | ≈79.9 | · | · | |
| P/S (TTM) | 3.45-Jahres-Durchschnitt ≈4.4 | ≈4.4 | · | · | |
| K/B (MRQ) | 2.85-Jahres-Durchschnitt ≈3.3 | ≈3.3 | · | · | |
| Kurs / FCF (TTM) | 22.05-Jahres-Durchschnitt ≈39.2 | ≈39.2 | · | · | |
| Kurs / Cashflow (TTM) | 15.85-Jahres-Durchschnitt ≈23.7 | ≈23.7 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 3.65-Jahres-Durchschnitt ≈100.9 | ≈100.9 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈2.3 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | STE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 44.4%5-Jahres-Durchschnitt ≈43.8% | ≈43.8% | · | · | |
| Betriebsgewinnmarge (TTM) | 18.9%5-Jahres-Durchschnitt ≈13.1% | ≈13.1% | · | · | |
| EBITDA-Marge (TTM) | 27.0%5-Jahres-Durchschnitt ≈23.3% | ≈23.3% | · | · | |
| Vorgewinnmarge (TTM) | 18.0%5-Jahres-Durchschnitt ≈11.2% | ≈11.2% | · | · | |
| Nettogewinnmarge (TTM) | 13.3%5-Jahres-Durchschnitt ≈7.9% | ≈7.9% | · | · | |
| ROA | 7.5%5-Jahres-Durchschnitt ≈4.1% | ≈4.1% | · | · | |
| ROE | 11.3%5-Jahres-Durchschnitt ≈6.7% | ≈6.7% | · | · | |
| ROIC | 9.1%5-Jahres-Durchschnitt ≈5.8% | ≈5.8% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | STE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.35-Jahres-Durchschnitt ≈0.4 | ≈0.4 | · | · | |
| Liquiditätsgrad (MRQ) | 1.95-Jahres-Durchschnitt ≈2.3 | ≈2.3 | · | · | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.25-Jahres-Durchschnitt ≈0.4 | ≈0.4 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | STE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 8.7%5-Jahres-Durchschnitt ≈14.3% | ≈14.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 9.4%5-Jahres-Durchschnitt ≈12.2% | ≈12.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 13.8% | · | · | · | |
| EPS YoY (EPS VjV) | 27.9%5-Jahres-Durchschnitt ≈48.7% | ≈48.7% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 27.3%5-Jahres-Durchschnitt ≈49.7% | ≈49.7% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 95.0%5-Jahres-Durchschnitt ≈41.5% | ≈41.5% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 11.4% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 94.1%5-Jahres-Durchschnitt ≈42.8% | ≈42.8% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 14.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | STE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover (Lagerumschlag) | 5.55-Jahres-Durchschnitt ≈5.0 | ≈5.0 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 5.65-Jahres-Durchschnitt ≈5.7 | ≈5.7 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$330.9K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite1.2%
Ausschüttungsquote30.9%
Annualisierte Auszahlung≈$2.76
5J Div CAGR≈8.2%
Wachstumsphase≈19
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Sep 4, 2026 | $0,69 | USD | ≈0.87% |
| Jun 8, 2026 | $0,63 | USD | ≈0.90% |
| Feb 17, 2026 | $0,63 | USD | ≈0.75% |
| Sep 4, 2025 | $0,63 | USD | ≈0.96% |
| Jun 10, 2025 | $0,57 | USD | ≈0.94% |
| Feb 20, 2025 | $0,57 | USD | ≈1.0% |
| Nov 19, 2024 | $0,57 | USD | ≈1.0% |
| Sep 5, 2024 | $0,57 | USD | ≈0.89% |
| Jun 12, 2024 | $0,52 | USD | ≈0.92% |
| Feb 22, 2024 | $0,52 | USD | ≈0.86% |
| Nov 20, 2023 | $0,52 | USD | ≈0.99% |
| Sep 5, 2023 | $0,52 | USD | ≈0.86% |
| Jun 13, 2023 | $0,47 | USD | ≈0.91% |
| Feb 23, 2023 | $0,47 | USD | ≈0.98% |
| Nov 21, 2022 | $0,47 | USD | ≈1.0% |
| Sep 6, 2022 | $0,47 | USD | ≈0.89% |
| Jun 13, 2022 | $0,43 | USD | ≈0.81% |
| Feb 24, 2022 | $0,43 | USD | ≈0.74% |
| Nov 22, 2021 | $0,43 | USD | ≈0.72% |
| Sep 2, 2021 | $0,43 | USD | ≈0.75% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
1.8%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | $2.59 | $2.53 | 2.5% | |
| 31. März 2026 | $2.83 | $2.88 | -1.6% | |
| 31. Dezember 2025 | $2.53 | $2.56 | -1.1% | |
| 30. September 2025 | $2.47 | $2.37 | 4.0% | |
| 30. Juni 2025 | $2.34 | $2.29 | 2.4% | |
| 31. März 2025 | $2.74 | $2.62 | 4.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | $2.62B | $2.61B | |
| Cost of Revenue | $3.31B | $3.06B | $2.92B | $2.56B | $2.34B | $1.76B | $1.71B | $1.61B | $1.53B | $1.59B | |
| Gross Profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B | $1.34B | $1.32B | $1.17B | $1.09B | $1.03B | |
| R&D Expense | $113M | $108M | $104M | $98M | $87M | $66M | $66M | $63M | $61M | $59M | |
| SG&A Expense | $1.41B | $1.33B | $1.25B | $1.09B | $1.32B | $731M | $717M | $670M | $632M | $682M | |
| Operating Expenses | $1.52B | $1.54B | $1.38B | $1.19B | $1.41B | $795M | $783M | $764M | $693M | $800M | |
| Operating Income | $1.10B | $867M | $836M | $791M | $478M | $548M | $537M | $411M | $400M | $226M | |
| Interest Expense | · | · | $144M | $108M | $89M | $37M | $40M | $45M | $51M | $45M | |
| Other Non-op | $10M | $8M | $11M | $-3M | $6M | $6M | $2M | $3M | $6M | $3M | |
| Pretax Income | $1.05B | $796M | $703M | $680M | $367M | $518M | $499M | $369M | $355M | $185M | |
| Income Tax | $262M | $185M | $150M | $124M | $82M | $121M | $91M | $64M | $63M | $74M | |
| Net Income | $782M | $615M | $378M | $107M | $244M | $397M | $408M | $304M | $291M | $110M | |
| EPS (Basic) | $7.97 | $6.24 | $3.83 | $1.07 | $2.50 | $4.66 | $4.81 | $3.59 | $3.42 | $1.29 | |
| EPS (Diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | $3.39 | $1.28 | |
| Shares (Basic) | 98,200,000 | 98,600,000 | 98,800,000 | 99,706,000 | 97,535,000 | 85,203,000 | 84,778,000 | 84,577,000 | 85,028,000 | 85,473,000 | |
| Shares (Diluted) | 98,700,000 | 99,100,000 | 99,400,000 | 100,246,000 | 98,326,000 | 85,898,000 | 85,641,000 | 85,468,000 | 85,713,000 | 86,094,000 | |
| EBITDA | $1.59B | $1.34B | $1.40B | $821M | $979M | $768M | $734M | $637M | · | · |
Bilanz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $440M | $172M | $207M | $208M | $348M | $221M | $320M | $221M | $202M | $283M | |
| Receivables | $1.09B | $1.04B | $1.01B | $865M | $799M | $609M | $586M | $565M | $528M | · | |
| Inventory | $632M | $581M | $675M | $604M | $575M | $315M | $264M | $208M | $206M | · | |
| Current Assets | $2.39B | $2.00B | $2.87B | $2.01B | $1.88B | $1.21B | $1.22B | $1.05B | $990M | · | |
| PP&E (Net) | $2.16B | $1.96B | $1.77B | $1.63B | $1.55B | $1.24B | $1.11B | $1.03B | $1.01B | · | |
| PP&E (Gross) | $4.11B | $3.69B | $3.34B | $3.05B | $2.82B | $2.39B | $2.13B | $1.99B | $1.85B | · | |
| Accum. Depreciation | $1.94B | $1.73B | $1.57B | $1.41B | $1.27B | $1.15B | $1.02B | $956M | $841M | · | |
| Goodwill | $4.19B | $4.10B | $4.07B | $3.88B | $3.94B | $3.03B | $2.36B | $2.32B | $2.43B | $2.23B | |
| Intangibles | $1.62B | $1.85B | $2.12B | $2.08B | $3.33B | $898M | $565M | $605M | $727M | · | |
| Other Non-current Assets | $211M | $83M | $66M | $78M | $71M | $53M | $52M | $60M | $39M | · | |
| Total Assets | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B | $6.57B | $5.44B | $5.07B | $5.20B | · | |
| Accounts Payable | $339M | $281M | $252M | $264M | $226M | $157M | $149M | $153M | $136M | · | |
| Accrued Liabilities | $402M | $368M | $320M | $298M | $307M | $221M | $192M | $188M | $168M | · | |
| Short-term Debt | $119M | $125M | $86M | $60M | $143M | $0 | $0 | · | · | · | |
| Current Liabilities | $1.15B | $1.02B | $931M | $862M | $922M | $578M | $504M | $465M | $398M | · | |
| Capital Leases | $120M | $125M | $146M | $140M | $155M | $130M | $114M | $0 | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $151M | $160M | · | |
| Other Non-current Liabilities | $72M | $62M | $72M | $76M | $76M | $88M | $90M | $88M | $109M | · | |
| Total Liabilities | $3.54B | $3.53B | $4.75B | $4.73B | $4.88B | $2.68B | $2.02B | $1.89B | $1.98B | · | |
| Long-term Debt | $1.81B | $1.92B | $3.12B | $3.02B | $2.95B | $1.65B | $1.15B | $1.18B | $1.32B | · | |
| Total Debt | $1.93B | $2.04B | $3.21B | $3.08B | $3.09B | $1.65B | $1.15B | $1.18B | · | · | |
| Common Stock | $4.28B | $4.42B | $4.54B | $4.49B | $4.74B | $2.00B | $1.98B | $2.00B | $2.05B | · | |
| Retained Earnings | $3.02B | $2.48B | $2.09B | $1.91B | $2.00B | $1.94B | $1.66B | $1.34B | $1.15B | · | |
| AOCI | $-113M | $-292M | $-329M | $-321M | $-210M | $-61M | $-235M | $-160M | $12M | $-241M | |
| Stockholders' Equity | $7.18B | $6.60B | $6.30B | $6.08B | $6.53B | $3.88B | $3.41B | $3.18B | $3.21B | · | |
| Liabilities + Equity | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B | $6.57B | $5.44B | $5.07B | $5.20B | · | |
| Shares Outstanding | 97,800,000 | 98,300,000 | 98,900,000 | 98,600,000 | 100,067,000 | 85,353,000 | 84,924,000 | 84,517,000 | 84,747,000 | · |
Cashflow
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $486M | $476M | $565M | $553M | $553M | $219M | $197M | $226M | $178M | $188M | |
| Stock-based Comp | $62M | $57M | $56M | $39M | $58M | $26M | $24M | $24M | $22M | $19M | |
| Deferred Tax | $-17M | $-76M | $-131M | $-186M | $-107M | $4M | $9M | $-7M | $-25M | $31M | |
| Amort. of Intangibles | $268M | $276M | $268M | $260M | $265M | $87M | $75M | $99M | $70M | $69M | |
| Restructuring | $3M | $62M | $44M | $485.0K | $48.0K | $-3M | $3M | $41M | $103.0K | $215.0K | |
| Other Non-cash | $28M | $76M | $105M | $244M | $-63M | $43M | $-48M | $-8M | · | · | |
| Operating Cash Flow | $1.34B | $1.15B | $973M | $757M | $685M | $690M | $591M | $540M | $458M | $424M | |
| CapEx | $369M | $370M | $360M | $362M | $288M | $239M | $215M | $190M | $165M | $173M | |
| Investing Cash Flow | $-512M | $389M | $-887M | $-383M | $-667M | $-1.15B | $-320M | $-213M | $-204M | $-104M | |
| Net Debt Issued | · | · | · | · | · | $-35M | $0 | $-85M | · | · | |
| Stock Repurchased | $236M | $211M | $12M | $309M | $56M | $15M | $51M | $81M | $65M | $98M | |
| Net Stock Activity | $-236M | $-211M | $-12M | $-309M | $-56M | $-15M | $-51M | $-81M | · | · | |
| Dividends Paid | $242M | $220M | $201M | $183M | $163M | $134M | $123M | $113M | $103M | $93M | |
| Financing Cash Flow | $-568M | $-1.57B | $-85M | $-499M | $116M | $346M | $-163M | $-295M | $-356M | $-267M | |
| Net Change in Cash | $268M | $-35M | $-1M | $-140M | $128M | $-99M | $99M | $19M | $-81M | $34M | |
| Taxes Paid | $289M | $274M | $271M | $255M | $138M | $110M | $92M | $65M | $86M | $78M | |
| Free Cash Flow | $972M | $778M | $613M | $395M | $397M | $450M | $376M | $350M | · | · | |
| Levered FCF | · | · | $499M | $322M | $328M | $422M | $343M | $313M | · | · |
Rentabilität
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2% | 44.0% | 43.2% | 43.6% | 44.0% | 43.2% | 43.5% | 42.2% | · | · | |
| Operating Margin | 18.6% | 15.9% | 16.3% | 5.4% | 9.3% | 17.6% | 17.7% | 14.8% | · | · | |
| Net Margin | 13.2% | 11.3% | 7.4% | 2.2% | 5.3% | 12.8% | 13.5% | 10.9% | · | · | |
| Pretax Margin | 17.6% | 14.6% | 13.7% | 3.2% | 6.9% | 16.7% | 16.4% | 13.3% | · | · | |
| EBITDA Margin | 26.8% | 24.6% | 27.3% | 16.6% | 21.3% | 24.7% | 24.2% | 22.9% | · | · | |
| ROA | 7.5% | 5.8% | 3.5% | 0.96% | 2.7% | 6.6% | 7.8% | 5.9% | · | · | |
| ROE | 11.3% | 9.5% | 6.1% | 1.7% | 4.7% | 10.9% | 12.4% | 9.5% | · | · | |
| ROIC | 9.1% | 7.7% | 6.9% | 2.0% | 3.4% | 7.6% | 9.7% | 7.8% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.0 | 3.1 | 2.3 | 2.0 | 2.1 | 2.4 | 2.3 | · | · | |
| Quick Ratio | 1.0 | 1.0 | 1.1 | 1.1 | 0.9 | 1.4 | 1.8 | 1.7 | · | · | |
| Debt / Equity | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | · | · | |
| LT Debt / Equity | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | · | · | |
| Interest Coverage | · | · | 5.8 | 2.5 | 4.8 | 14.7 | 13.3 | 9.1 | · | · |
Effizienz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | · | · | |
| Inventory Turnover | 5.5 | 4.9 | 4.6 | 4.4 | 5.8 | 6.1 | 7.5 | 7.8 | · | · | |
| Receivables Turnover | 5.6 | 5.3 | 5.5 | 5.7 | 6.5 | 5.2 | 5.3 | 5.1 | · | · |
Pro Aktie
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $73.45 | $67.18 | $63.73 | $61.62 | $65.28 | $45.47 | $39.96 | $37.60 | · | · | |
| Revenue / Share | $60.14 | $55.11 | $51.72 | $49.46 | $46.63 | $36.18 | $35.39 | $32.55 | · | · | |
| Cash Flow / Share | $13.59 | $11.59 | $9.80 | $7.55 | $6.96 | $8.03 | $6.90 | $6.31 | · | · | |
| Cash / Share | · | · | · | · | · | $2.58 | $3.76 | $2.61 | · | · | |
| Dividend / Share | $2.46 | $2.23 | $2.03 | $1.84 | $1.69 | $1.57 | $1.45 | $1.33 | $1.21 | $1.09 | |
| Dividend Paid / Share | $2.46 | $2.23 | $2.03 | $1.84 | $1.69 | $1.57 | $1.45 | $1.33 | $1.21 | $1.09 | |
| EPS (TTM) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.7% | 6.2% | 13.3% | 7.4% | 35.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.4% | 8.9% | 18.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 13.8% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 27.9% | 62.7% | 256.1% | -56.9% | -46.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 95.0% | 35.7% | -6.3% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 27.3% | 62.5% | 253.4% | -56.1% | -38.6% | · | · | · | · | · | |
| Net Income CAGR 3Y | 94.1% | 36.1% | -1.6% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 14.5% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | · | · | |
| Net Income TTM | $782M | $615M | $378M | $107M | $244M | $397M | $408M | $304M | · | · | |
| Market Cap | $21.63B | $22.28B | $22.23B | $18.87B | $24.19B | $16.26B | $11.89B | $10.82B | · | · | |
| Enterprise Value | · | · | · | · | · | $17.69B | $12.72B | $11.78B | · | · | |
| P/E | 27.9 | 36.6 | 59.0 | 178.8 | 97.5 | 41.1 | 29.4 | 36.1 | · | · | |
| P/S | 3.6 | 4.1 | 4.3 | 4.2 | 5.7 | 5.2 | 3.9 | 3.9 | · | · | |
| P/B | 3.0 | 3.4 | 3.5 | 3.1 | 3.7 | 4.2 | 3.5 | 3.4 | · | · | |
| P / Tangible Book | 15.8 | 34.1 | 198.2 | 155.6 | · | · | · | · | · | · | |
| P / Cash Flow | 16.1 | 19.4 | 22.8 | 24.9 | 35.3 | 23.6 | 20.1 | 20.1 | · | · | |
| P / FCF | 22.2 | 28.6 | 36.3 | 47.8 | 60.9 | 36.1 | 31.6 | 30.9 | · | · | |
| EV / EBITDA | · | · | · | · | · | 23.0 | 17.3 | 18.5 | · | · | |
| EV / FCF | · | · | · | · | · | 39.3 | 33.8 | 33.7 | · | · | |
| EV / Revenue | · | · | · | · | · | 5.7 | 4.2 | 4.2 | · | · | |
| Dividend Yield | 1.1% | 0.99% | 0.90% | 0.97% | 0.67% | 0.82% | 1.0% | 1.0% | · | · | |
| Earnings Yield | 3.6% | 2.7% | 1.7% | 0.56% | 1.0% | 2.4% | 3.4% | 2.8% | · | · | |
| Payout Ratio | 30.9% | 35.8% | 53.0% | 171.4% | 66.9% | 33.7% | 30.2% | 37.0% | · | · | |
| Annual Payout | $242M | $220M | $201M | $183M | $163M | $134M | $123M | $113M | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | $1.48B | $1.37B | $1.33B | $1.28B | $1.42B | $1.30B | $1.24B | $1.18B | $963M | $1.11B | $1.09B | |
| Cost of Revenue | $809M | $891M | $841M | $814M | $763M | $839M | $760M | $750M | $707M | $836M | $738M | $692M | $654M | $554M | $634M | $609M | |
| Gross Profit | $684M | $697M | $656M | $646M | $628M | $641M | $610M | $579M | $572M | $583M | $560M | $546M | $529M | $409M | $478M | $482M | |
| R&D Expense | $29M | $29M | $30M | $28M | $26M | $28M | $27M | $27M | $26M | $27M | $25M | $26M | $25M | $23M | $26M | $25M | |
| SG&A Expense | $370M | $352M | $352M | $350M | $354M | $334M | $336M | $329M | $336M | $309M | $308M | $328M | $307M | $128M | $305M | $323M | |
| Operating Expenses | $398M | $380M | $382M | $380M | $382M | $425M | $365M | $359M | $387M | $363M | $334M | $355M | $331M | $-339M | $331M | $839M | |
| Operating Income | $286M | $317M | $273M | $266M | $246M | $216M | $245M | $220M | $186M | $220M | $226M | $192M | $198M | $748M | $191M | $-306M | |
| Interest Expense | · | · | · | · | · | · | · | · | $30M | · | $39M | $37M | $32M | · | $29M | $26M | |
| Other Non-op | $3M | $3M | $3M | $2M | $2M | $4M | $2M | $1M | $1M | $6M | $2M | $1M | $1M | $321.0K | $-2M | $-524.0K | |
| Pretax Income | $274M | $304M | $258M | $253M | $232M | $197M | $229M | $195M | $175M | $191M | $190M | $156M | $167M | $718M | $172M | $159M | |
| Income Tax | $72M | $84M | $64M | $61M | $54M | $50M | $55M | $44M | $35M | $37M | $41M | $35M | $36M | $81M | $41M | $35M | |
| Net Income | $200M | $220M | $193M | $192M | $177M | $146M | $174M | $150M | $145M | $-1M | $141M | $115M | $124M | $187M | $124M | $-315M | |
| EPS (Basic) | · | $2.26 | $1.96 | $1.95 | $1.80 | $1.49 | $1.76 | $1.52 | $1.47 | $-0.01 | $1.42 | $1.17 | $1.25 | $1.87 | $1.24 | $-3.15 | |
| EPS (Diluted) | · | $2.24 | $1.96 | $1.94 | $1.79 | $1.48 | $1.75 | $1.51 | $1.46 | $-0.02 | $1.42 | $1.16 | $1.25 | $1.88 | $1.24 | $-3.15 | |
| Shares (Basic) | 97,600,000 | · | 98,200,000 | 98,400,000 | 98,400,000 | · | 98,500,000 | 98,700,000 | 98,900,000 | · | 98,802,000 | 98,785,000 | 98,708,000 | · | 99,716,000 | 99,969,000 | |
| Shares (Diluted) | 97,900,000 | · | 98,600,000 | 98,800,000 | 98,800,000 | · | 98,900,000 | 99,200,000 | 99,400,000 | · | 99,354,000 | 99,406,000 | 99,239,000 | · | 100,166,000 | 99,969,000 | |
| EBITDA | $410M | · | $273M | $266M | $365M | · | $245M | $220M | $298M | · | $216M | $186M | $327M | · | $191M | $-306M |
Bilanz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $482M | · | $424M | $319M | $280M | · | $155M | $172M | $198M | · | $196M | $214M | $209M | · | $259M | $258M | |
| Receivables | $1.01B | $1.09B | $991M | $947M | $947M | $1.04B | $915M | $923M | $893M | $1.01B | $964M | $940M | $888M | · | $823M | $780M | |
| Inventory | $712M | $632M | $674M | $658M | $641M | $581M | $650M | $689M | $699M | $675M | $856M | $821M | $769M | · | $694M | $645M | |
| Current Assets | $2.45B | $2.39B | $2.29B | $2.11B | $2.06B | $2.00B | $1.90B | $1.94B | $1.94B | $2.87B | $2.22B | $2.17B | $2.03B | · | $1.98B | $1.89B | |
| PP&E (Net) | $2.17B | $2.16B | $2.13B | $2.09B | $2.05B | $1.96B | $1.92B | $1.93B | $1.83B | $1.77B | $1.84B | $1.74B | $1.73B | · | $1.67B | $1.57B | |
| PP&E (Gross) | $4.17B | $4.11B | $4.05B | $3.96B | $3.87B | $3.69B | $3.61B | $3.60B | $3.44B | $3.34B | $3.41B | $3.25B | $3.20B | · | $3.06B | $2.90B | |
| Accum. Depreciation | $2.00B | $1.94B | $1.92B | $1.86B | $1.82B | $1.73B | $1.68B | $1.67B | $1.61B | $1.57B | $1.56B | $1.51B | $1.48B | · | $1.38B | $1.32B | |
| Goodwill | $4.19B | $4.19B | $4.23B | $4.22B | $4.22B | $4.10B | $4.04B | $4.15B | $4.06B | $4.07B | $4.11B | $4.04B | $3.89B | $3.88B | $3.85B | $3.71B | |
| Intangibles | $1.56B | $1.62B | $1.69B | $1.75B | $1.82B | $1.85B | $1.92B | $2.00B | $2.05B | $2.12B | $2.99B | $3.06B | $2.87B | · | $3.03B | $3.08B | |
| Other Non-current Assets | $215M | $211M | $94M | $88M | $89M | $83M | $68M | $60M | $63M | $66M | $77M | $73M | $80M | · | $80M | $72M | |
| Total Assets | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $10.11B | $11.06B | $11.44B | $11.28B | $10.78B | · | $10.80B | $10.49B | |
| Accounts Payable | $344M | $339M | $285M | $309M | $301M | $281M | $238M | $235M | $232M | $252M | $277M | $294M | $261M | · | $242M | $233M | |
| Accrued Liabilities | $420M | $402M | $405M | $360M | $371M | $368M | $335M | $307M | $287M | $320M | $318M | $307M | $333M | · | $303M | $304M | |
| Short-term Debt | $243M | $119M | $0 | $0 | $0 | $125M | $125M | $80M | $80M | $86M | $78M | $71M | $63M | · | $60M | $151M | |
| Current Liabilities | $1.28B | $1.15B | $922M | $889M | $927M | $1.02B | $891M | $805M | $834M | $931M | $914M | $873M | $887M | · | $796M | $873M | |
| Capital Leases | · | $120M | · | · | · | $125M | · | · | · | $146M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $75M | $72M | $67M | $64M | $64M | $62M | $73M | $74M | $72M | $72M | $78M | $77M | $77M | · | $73M | $76M | |
| Total Liabilities | $3.51B | $3.54B | $3.42B | $3.39B | $3.44B | $3.53B | $3.58B | $3.63B | $3.74B | $4.75B | $5.01B | $5.09B | $4.61B | · | $4.75B | $4.68B | |
| Long-term Debt | $1.65B | $1.81B | $1.90B | $1.90B | $1.90B | $1.92B | $2.04B | $2.16B | $2.24B | $3.12B | $3.23B | $3.37B | $2.86B | · | $3.00B | $2.87B | |
| Total Debt | $1.89B | · | $1.90B | $1.90B | $1.90B | · | $2.16B | $2.24B | $2.32B | · | $3.31B | $3.44B | $2.92B | · | $3.06B | $3.02B | |
| Common Stock | $4.18B | $4.28B | $4.34B | $4.36B | $4.43B | $4.42B | $4.40B | $4.49B | $4.50B | $4.54B | $4.53B | $4.52B | $4.50B | · | $4.63B | $4.71B | |
| Retained Earnings | $3.15B | $3.02B | $2.86B | $2.73B | $2.60B | $2.48B | $2.39B | $2.27B | $2.18B | $2.09B | $2.13B | $2.05B | $1.98B | · | $1.77B | $1.70B | |
| AOCI | $-127M | $-113M | $-43M | $-76M | $-70M | $-292M | $-374M | $-166M | $-323M | $-329M | $-253M | $-387M | $-311M | $-321M | $-364M | $-598M | |
| Stockholders' Equity | $7.21B | $7.18B | $7.15B | $7.01B | $6.96B | $6.60B | $6.42B | $6.59B | $6.35B | $6.30B | $6.42B | $6.18B | $6.17B | · | $6.04B | $5.80B | |
| Liabilities + Equity | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $10.11B | $11.06B | $11.44B | $11.28B | $10.78B | · | $10.80B | $10.49B | |
| Shares Outstanding | 97,500,000 | 97,800,000 | 98,100,000 | 98,100,000 | 98,500,000 | 98,300,000 | 98,245,000 | 98,708,000 | 98,799,000 | 98,900,000 | 98,808,000 | 98,789,000 | 98,781,000 | 98,629,000 | 99,401,000 | 99,868,000 |
Cashflow
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $124M | $123M | $122M | $122M | $119M | $122M | $126M | $115M | $113M | $134M | $141M | $152M | $138M | $142M | $138M | $134M | |
| Stock-based Comp | $13M | $13M | $16M | $21M | $12M | $10M | $15M | $21M | $12M | $9M | $15M | $21M | $12M | $9M | $9M | $12M | |
| Deferred Tax | $600.0K | $-17M | $-100.0K | $-100.0K | $0 | $-53M | $-2M | $21.0K | $-22M | $-131M | $808.0K | $-869.0K | $-445.0K | $-123M | $101.0K | $-68M | |
| Restructuring | · | $300.0K | $100.0K | $1M | $2M | $29M | $2M | $3M | $28M | $44M | $6.0K | $-23.0K | $19.0K | $359.0K | $38.0K | $62.0K | |
| Other Non-cash | $30M | · | · | · | $111M | · | · | · | $56M | · | · | · | $9M | · | · | · | |
| Operating Cash Flow | $367M | $335M | $298M | $288M | $420M | $261M | $333M | $251M | $304M | $255M | $291M | $146M | $281M | $216M | $206M | $104M | |
| CapEx | $88M | $90M | $99M | $86M | $94M | $71M | $89M | $102M | $108M | $91M | $119M | $83M | $67M | $71M | $92M | $83M | |
| Investing Cash Flow | $-108M | $-217M | $-98M | $-88M | $-108M | $-70M | $-124M | $-105M | $688M | $-96M | $-119M | $-606M | $-67M | $-78M | $-98M | $-98M | |
| Stock Repurchased | $116M | $74M | $50M | $100M | $11M | $200.0K | $100M | $46M | $64M | $359.0K | $2M | $489.0K | $9M | $155M | $84M | $45M | |
| Net Stock Activity | $-116M | · | · | · | $-11M | · | · | $-46M | $-64M | · | $-2M | $-489.0K | $-9M | · | $-84M | $-45M | |
| Dividends Paid | $61M | $62M | $62M | $62M | $56M | $56M | $56M | $56M | $51M | $51M | $51M | $51M | $46M | $47M | $47M | $47M | |
| Financing Cash Flow | $-214M | $-98M | $-98M | $-159M | $-213M | $-178M | $-214M | $-181M | $-999M | $-144M | $-198M | $470M | $-214M | $-192M | $-120M | $-45M | |
| Net Change in Cash | $43M | $16M | $104M | $40M | $108M | $16M | $-17M | $-26M | $-9M | $11M | $-18M | $5M | $257.0K | $-51M | $1M | $-58M | |
| Free Cash Flow | $280M | · | · | · | $326M | · | · | · | $196M | · | · | · | $215M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $171M | · | · | · | $189M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.8% | · | 43.8% | 44.2% | 45.1% | · | 44.5% | 43.5% | 44.7% | · | 43.2% | 44.2% | 44.6% | · | 42.9% | 44.3% | |
| Operating Margin | 19.1% | · | 18.3% | 18.2% | 17.7% | · | 17.9% | 16.5% | 14.5% | · | 15.5% | 13.9% | 14.7% | · | 15.7% | -25.5% | |
| Net Margin | 13.4% | · | 12.9% | 13.1% | 12.8% | · | 12.7% | 11.3% | 11.4% | · | 10.1% | 8.6% | 9.6% | · | 10.2% | -26.3% | |
| Pretax Margin | 18.3% | · | 17.2% | 17.3% | 16.7% | · | 16.7% | 14.7% | 13.7% | · | 12.8% | 11.2% | 12.3% | · | 13.2% | -27.7% | |
| EBITDA Margin | 27.4% | · | 18.3% | 18.2% | 26.3% | · | 17.9% | 16.5% | 23.3% | · | 15.5% | 13.9% | 25.4% | · | 15.7% | -25.5% | |
| ROA | 1.9% | · | 1.9% | 1.9% | 1.7% | · | 1.6% | 1.4% | 1.4% | · | 1.3% | 1.1% | 1.1% | · | 1.1% | -2.8% | |
| ROE | 2.8% | · | 2.8% | 2.8% | 2.7% | · | 2.7% | 2.4% | 2.3% | · | 2.3% | 1.9% | 2.0% | · | 2.0% | -5.1% | |
| ROIC | 2.3% | · | 2.3% | 2.3% | 2.1% | · | 2.2% | 1.9% | 1.7% | · | 1.8% | 1.5% | 1.6% | · | 1.6% | -3.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | · | 2.5 | 2.4 | 2.2 | · | 2.1 | 2.4 | 2.3 | · | 2.4 | 2.5 | 2.3 | · | 2.5 | 2.2 | |
| Quick Ratio | 1.2 | · | 1.5 | 1.4 | 1.3 | · | 1.2 | 1.4 | 1.3 | · | 1.3 | 1.3 | 1.2 | · | 1.4 | 1.2 | |
| Debt / Equity | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| LT Debt / Equity | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 6.1 | · | 5.5 | 5.0 | 5.8 | · | 6.7 | -11.7 |
Effizienz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.1 | 1.1 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.6 | 1.5 | · | 1.5 | 1.4 | 1.4 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.6 |
Pro Aktie
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $73.91 | · | $72.93 | $71.45 | $70.63 | · | $65.31 | $66.80 | $64.32 | · | $64.93 | $62.54 | $62.44 | · | $60.75 | $58.10 | |
| Revenue / Share | $15.25 | · | $15.17 | $14.78 | $14.08 | · | $13.85 | $13.40 | $12.88 | · | $14.05 | $13.50 | $12.94 | · | $12.14 | · | |
| Cash Flow / Share | $3.75 | · | · | · | $4.25 | · | · | · | $3.06 | · | · | · | $2.83 | · | · | · | |
| Cash / Share | $4.95 | · | $4.32 | $3.25 | $2.84 | · | $1.58 | $1.74 | $2.01 | · | $1.98 | $2.16 | $2.11 | · | $2.61 | $2.59 | |
| Dividend / Share | $0.63 | $0.63 | $0.63 | $0.63 | $0.57 | $0.57 | $0.57 | $0.57 | $0.52 | $0.52 | $0.52 | $0.52 | $0.47 | $0.47 | $0.47 | $0.47 | |
| Dividend Paid / Share | $0.63 | $0.63 | $0.63 | $0.63 | $0.57 | $0.62 | $0.57 | $0.52 | $0.52 | $0.52 | $0.52 | $0.52 | $0.47 | $0.47 | $0.47 | $0.47 | |
| EPS (TTM) | $7.93 | · | $7.17 | $6.96 | $6.53 | · | $4.70 | $4.37 | $4.02 | · | $5.71 | $5.53 | $1.22 | · | $-0.20 | $-0.02 |
Bewertung (TTM)
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.04B | · | $5.83B | $5.70B | $5.57B | · | $5.40B | $5.33B | $5.23B | · | $4.68B | $4.50B | $4.35B | · | $4.10B | $4.20B | |
| Net Income TTM | $805M | · | $708M | $688M | $647M | · | $467M | $435M | $400M | · | $567M | $550M | $119M | · | $-28M | $-8M | |
| Market Cap | $20.53B | · | $24.87B | $24.27B | $23.66B | · | $20.20B | $23.94B | $21.69B | · | $21.72B | $21.68B | $22.22B | · | $18.36B | $16.61B | |
| Enterprise Value | $21.94B | · | $26.35B | $25.85B | $25.29B | · | $22.20B | $26.00B | $23.81B | · | $24.84B | $24.90B | $24.94B | · | $21.16B | $19.37B | |
| P/E | 26.6 | · | 35.4 | 35.6 | 36.8 | · | 43.7 | 55.5 | 54.6 | · | 38.5 | 39.7 | 184.4 | · | -923.5 | -8314.0 | |
| P/S | 3.4 | · | 4.3 | 4.3 | 4.2 | · | 3.7 | 4.5 | 4.1 | · | 4.6 | 4.8 | 5.1 | · | 4.5 | 4.0 | |
| P/B | 2.8 | · | 3.5 | 3.5 | 3.4 | · | 3.1 | 3.6 | 3.4 | · | 3.4 | 3.5 | 3.6 | · | 3.0 | 2.9 | |
| P / Tangible Book | 14.1 | · | 20.2 | 23.2 | 25.8 | · | 45.0 | 54.6 | 87.2 | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.9 | · | · | · | 56.3 | · | · | · | 71.4 | · | · | · | 79.1 | · | · | · | |
| EV / Revenue | 3.6 | · | 4.5 | 4.5 | 4.5 | · | 4.1 | 4.9 | 4.5 | · | 5.3 | 5.5 | 5.7 | · | 5.2 | 4.6 | |
| Dividend Yield | 1.2% | · | 0.95% | 0.95% | 0.95% | · | 1.1% | 0.88% | 0.95% | · | 0.90% | 0.88% | 0.84% | · | 0.98% | 1.1% | |
| Earnings Yield | 3.8% | · | 2.8% | 2.8% | 2.7% | · | 2.3% | 1.8% | 1.8% | · | 2.6% | 2.5% | 0.54% | · | -0.11% | -0.01% | |
| Payout Ratio | 30.7% | · | · | · | 31.7% | · | · | · | 35.4% | · | · | · | 37.6% | · | · | · | |
| Annual Payout | $247M | · | $236M | $230M | $225M | · | $215M | $210M | $206M | · | $196M | $191M | $187M | · | $180M | $176M |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Umsatz | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B |
| Bruttogewinnmarge % | 44.2% | 44.0% | 43.2% | 43.6% | 44.0% |
| Betriebsgewinnmarge % | 18.6% | 15.9% | 16.3% | 5.4% | 9.3% |
| Nettoergebnis | $782M | $615M | $378M | $107M | $244M |
| Verwässerte EPS | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 |
| Liquiditätsgrad | 2.1 | 2.0 | 3.1 | 2.3 | 2.0 |
| Quick Ratio | 1.0 | 1.0 | 1.1 | 1.1 | 0.9 |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $972M | $778M | $613M | $395M | $397M |
Institutionelle Eigentümer (13F) 880 Einreicher · $22.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
880
Gehaltener Wert
$22.6B
Neue Positionen
99
Geschlossene Positionen
99
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 99 (-4 vs. Vorquartal) | 99 (-23 vs. Vorquartal) | 293 (+28 vs. Vorquartal) | 306 (-34 vs. Vorquartal) | +844K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.114.882.353 | 12.286.535 | 13,80% | Aktien |
| BlackRock, Inc. | $1.857.414.656 | 8.820.889 | 8,23% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.349.102.196 | 6.406.906 | 5,98% | Aktien |
| STATE STREET CORP | $1.068.232.039 | 5.072.818 | 4,73% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.053.260.612 | 5.001.950 | 4,67% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $850.363.483 | 3.801.077 | 3,77% | Aktien |
| MORGAN STANLEY | $831.766.442 | 3.950.067 | 3,69% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $737.605.022 | 3.502.897 | 3,27% | Aktien |
| Orbis Allan Gray Ltd | $563.845.394 | 2.677.710 | 2,50% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $548.620.258 | 2.615.842 | 2,43% | Aktien |
| GENERATION INVESTMENT MANAGEMENT LLP | $480.246.578 | 2.280.698 | 2,13% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $463.300.325 | 2.200.220 | 2,05% | Aktien |
| JANUS HENDERSON GROUP PLC | $411.994.872 | 1.863.139 | 1,83% | Aktien |
| Select Equity Group, L.P. | $398.955.608 | 1.894.646 | 1,77% | Aktien |
| Invesco Ltd. | $380.328.852 | 1.806.187 | 1,69% | Aktien |
| Boston Partners | $315.497.209 | 1.498.334 | 1,40% | Aktien |
| GOLDMAN SACHS GROUP INC | $287.037.463 | 1.363.145 | 1,27% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $285.844.205 | 1.377.297 | 1,27% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $277.186.897 | 1.253.502 | 1,23% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $256.445.622 | 1.217.864 | 1,14% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $252.635.989 | 1.199.619 | 1,12% | Aktien |
| NORGES BANK | $251.035.869 | 1.192.173 | 1,11% | Aktien |
| NORTHERN TRUST CORP | $194.908.435 | 925.623 | 0,86% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $188.588.689 | 895.576 | 0,84% | Aktien |
| BANK OF AMERICA CORP /DE/ | $175.849.376 | 835.111 | 0,78% | Aktien |
| Legal & General Group Plc | $154.205.042 | 732.322 | 0,68% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $140.372.911 | 666.633 | 0,62% | Aktien |
| Findlay Park Partners LLP | $138.494.626 | 657.713 | 0,61% | Aktien |
| LONDON CO OF VIRGINIA | $135.103.429 | 641.604 | 0,60% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $127.005.820 | 603.153 | 0,56% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $115.966.163 | 550.725 | 0,51% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $112.852.811 | 510.346 | 0,50% | Aktien |
| DEUTSCHE BANK AG\ | $112.363.310 | 533.615 | 0,50% | Aktien |
| Amundi | $108.100.953 | 513.373 | 0,48% | Aktien |
| D. E. Shaw & Co., Inc. | $107.308.578 | 509.610 | 0,48% | Aktien |
| Bank of New York Mellon Corp | $106.001.338 | 503.402 | 0,47% | Aktien |
| JPMORGAN CHASE & CO | $104.490.709 | 490.014 | 0,46% | Aktien |
| LOCUST WOOD CAPITAL ADVISERS, LLC | $95.991.742 | 455.866 | 0,43% | Aktien |
| ROYAL LONDON ASSET MANAGEMENT LTD | $89.099.538 | 423.135 | 0,39% | Aktien |
| CITADEL ADVISORS LLC | $85.126.292 | 404.266 | 0,38% | Aktien |
| UBS Group AG | $83.596.501 | 397.001 | 0,37% | Aktien |
| Nuveen, LLC | $80.563.873 | 382.600 | 0,36% | Aktien |
| Sustainable Growth Advisers, LP | $79.013.655 | 375.237 | 0,35% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $78.455.434 | 372.586 | 0,35% | Aktien |
| Fenimore Asset Management Inc | $74.796.972 | 355.212 | 0,33% | Aktien |
| Williams Jones Wealth Management, LLC. | $70.114.973 | 332.977 | 0,31% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $66.103.000 | 313.924 | 0,29% | Aktien |
| Life Cycle Investment Partners Ltd | $63.595.720 | 302.017 | 0,28% | Aktien |
| Boston Trust Walden Corp | $63.265.756 | 300.450 | 0,28% | Aktien |
| Gotham Asset Management, LLC | $62.307.242 | 295.898 | 0,28% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| STERIS plc, Solar New US Holding Co, LLC, Crystal Merger Sub 1, LLC | 22. Januar 2021 | · | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 31 Insider · 16 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel A Carestio | President and CEO | 5. Juni 2026 S | 63.647 | 0 | 3 | $-985.248 |
| Walter M Rosebrough Jr | President & CEO | 9. November 2020 S | 51.405 | 0 | 0 | $0 |
| Karen L Burton | Sr. Vice Pres., CFO | 4. Juni 2026 F | 13.184 | 0 | 0 | $0 |
| Michael J Tokich | Sr. Vice Pres., CFO | 4. Juni 2025 F | 43.891 | 0 | 0 | $0 |
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 15. Juni 2026 S | 35.259 | 0 | 2 | $-4.274.068 |
| Kenneth E Kohler | SVP & GM, AST | 4. Juni 2026 F | 11.332 | 0 | 0 | $0 |
| Julia Madsen | Sr. VP and GM, Life Sciences | 4. Juni 2026 F | 12.257 | 0 | 2 | $-1.312.096 |
| Mary Clare Fraser | SVP & Chief HRO | 4. Juni 2026 F | 13.716 | 0 | 0 | $0 |
| Renato Tamaro | V.P. & Corporate Treasurer | 4. Juni 2026 F | 6.194 | 0 | 3 | $-1.297.039 |
| Lindsey Mcgowan | VP, Chf. Comp. & Quality Offc. | 2. Juni 2026 A | 5.656 | 0 | 0 | $0 |
| Cary L Majors | SVP and President, Healthcare | 2. Juni 2026 A | 17.338 | 0 | 0 | $0 |
| Andrew Xilas | SVP and GM, Dental | 31. Mai 2024 F | 6.347 | 0 | 0 | $0 |
| Kathleen Bardwell | Sr.V. P. & C.C.O. | 28. Juni 2019 M | 17.428 | 0 | 0 | $0 |
| Adrian Vincent Coward | Sr. V P, Healthcare Spec Serv | 31. Mai 2019 A | 25.119 | 0 | 0 | $0 |
| Gulam Amjad Khan | Sr. V.P., Procedural Solutions | 31. Mai 2019 A | 14.685 | 0 | 0 | $0 |
| Michiel Dezwaan | V.P., Human Resources & CHRO | 28. März 2019 A | 30 | 0 | 0 | $0 |
| Mohsen Sohi | Direktor | 12. August 2026 M | 24.305 | 0 | 1 | $-956.795 |
| Pierre Boulud | Direktor | 10. August 2026 A | · | 0 | 0 | $0 |
| Louis Shapiro | Direktor | 10. August 2026 A | · | 0 | 0 | $0 |
| Esther M. Alegria | Direktor | 10. August 2026 A | · | 0 | 0 | $0 |
| Nirav R Shah | Direktor | 10. August 2026 A | 292 | 0 | 0 | $0 |
| Paul Edward Martin | Direktor | 10. August 2026 A | · | 0 | 0 | $0 |
| Christopher S Holland | Direktor | 10. August 2026 A | 582 | 0 | 0 | $0 |
| Cynthia L Feldmann | Direktor | 10. August 2026 A | 705 | 0 | 1 | $-734.877 |
| Richard C Breeden | Direktor | 2. Juni 2026 M | 38.964 | 0 | 1 | $-310.284 |
| Richard Martin Steeves | Direktor | 8. August 2024 A | 0 | 0 | 0 | $0 |
| Jacqueline B Kosecoff | Direktor | 8. August 2024 A | 0 | 0 | 0 | $0 |
| David B Lewis | Direktor | 21. Juli 2021 M | 8.245 | 0 | 0 | $0 |
| Loyal W Wilson | Direktor | 4. Juni 2019 M | 24.000 | 0 | 0 | $0 |
| Michael B Wood | Direktor | 16. Mai 2019 S | 16.631 | 0 | 0 | $0 |
| Duncan K Nichol | Direktor | 28. März 2019 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 107 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 3,14% | 468.870 SH | 11. September 2026 | Täglich |
| POWA · Invesco Exchange-Traded Self-Indexe… | 1,88% | 14.818 SH | 2. Oktober 2026 | Täglich |
| NUMV · Nushares ETF Trust | 1,62% | 31.484 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,61% | 66.867 SH | 2. Oktober 2026 | Täglich |
| NUDV · Nushares ETF Trust | 0,95% | 2.081 NS | 31. Juli 2026 | N-PORT |
| SUSA · iShares Trust | 0,63% | 119.264 SH | 11. September 2026 | Täglich |
| EVUS · iShares Trust | 0,49% | 8.778 SH | 11. September 2026 | Täglich |
| NULV · Nushares ETF Trust | 0,40% | 38.341 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,34% | 57.333 SH | 11. September 2026 | Täglich |
| VFMV · VANGUARD WELLINGTON FUND | 0,33% | 6.491 SH | 19. August 2026 | Täglich |
| ESGU · iShares Trust | 0,32% | 272.491 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,30% | 294.875 SH | 19. August 2026 | Täglich |
| IXJ · iShares Trust | 0,26% | 51.423 SH | 11. September 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,26% | 1.930 NS | 31. Juli 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0,23% | 375.677 SH | 19. August 2026 | Täglich |
| ESLG · Strategy Shares | 0,22% | 225 NS | 31. Juli 2026 | N-PORT |
| IWS · iShares Trust | 0,20% | 146.233 SH | 11. September 2026 | Täglich |
| VO · VANGUARD INDEX FUNDS | 0,20% | 2.125.301 SH | 19. August 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 907.382 SH | 2. Oktober 2026 | Täglich |
| SIZE · iShares Trust | 0,19% | 3.854 SH | 11. September 2026 | Täglich |
| EUSA · iShares, Inc. | 0,18% | 16.470 SH | 11. September 2026 | Täglich |
| VOE · VANGUARD INDEX FUNDS | 0,18% | 315.003 SH | 19. August 2026 | Täglich |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,18% | 159.004 SH | 2. Oktober 2026 | Täglich |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,17% | 69.786 SH | 2. Oktober 2026 | Täglich |
| ESUM · Strategy Shares | 0,17% | 1.373 NS | 31. Juli 2026 | N-PORT |
| IMCV · iShares Trust | 0,17% | 9.269 SH | 11. September 2026 | Täglich |
| IDHQ · Invesco Exchange-Traded Fund Trust … | 0,16% | 207.104 SH | 2. Oktober 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 0,16% | 47.873 NS | 31. Juli 2026 | N-PORT |
| ESMV · iShares Trust | 0,16% | 59 SH | 11. September 2026 | Täglich |
| IWR · iShares Trust | 0,15% | 400.582 SH | 11. September 2026 | Täglich |
| ESLV · Strategy Shares | 0,15% | 93 NS | 31. Juli 2026 | N-PORT |
| IMCB · iShares Trust | 0,15% | 11.557 SH | 11. September 2026 | Täglich |
| IMCG · iShares Trust | 0,12% | 23.208 SH | 11. September 2026 | Täglich |
| XOEF · iShares Trust | 0,12% | 122 SH | 11. September 2026 | Täglich |
| CATH · Global X Funds | 0,11% | 6.055 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,10% | 67.539 NS | 31. Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3.558 SH | 2. Oktober 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,09% | 130.000 | 2. Oktober 2026 | Täglich |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,09% | 554.067 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,09% | 2.140 NS | 31. Juli 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,08% | 931.689 SH | 19. August 2026 | Täglich |
| PFM · Invesco Exchange-Traded Fund Trust | 0,08% | 2.780 SH | 2. Oktober 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,07% | 10.863 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,07% | 154.755 NS | 31. Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,07% | 16.155 SH | 2. Oktober 2026 | Täglich |
| CHRI · Global X Funds | 0,07% | 24 NS | 31. Juli 2026 | N-PORT |
| SUSL · iShares Trust | 0,06% | 3.429 SH | 11. September 2026 | Täglich |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0,06% | 75.373 SH | 2. Oktober 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 59.118 SH | 19. August 2026 | Täglich |
| DSI · iShares Trust | 0,06% | 15.165 SH | 11. September 2026 | Täglich |
| CRBN · iShares Trust | 0,06% | 3.088 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,06% | 217.252 SH | 11. September 2026 | Täglich |
| DGRO · iShares Trust | 0,05% | 110.714 SH | 11. September 2026 | Täglich |
| EGLE · Global X Funds | 0,05% | 5 NS | 31. Juli 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,05% | 4.010 SH | 2. Oktober 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,04% | 23.890 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 4.327 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 1.998 SH | 2. Oktober 2026 | Täglich |
| TOPC · iShares Trust | 0,04% | 62 SH | 11. September 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 11.347 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,04% | 22.125 SH | 19. August 2026 | Täglich |
| XYLG · Global X Funds | 0,04% | 112 NS | 31. Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,04% | 5.420 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,04% | 1.132 SH | 11. September 2026 | Täglich |
| VOTE · TCW ETF Trust | 0,03% | 1.670 NS | 31. Juli 2026 | N-PORT |
| IVE · iShares Trust | 0,03% | 80.778 SH | 11. September 2026 | Täglich |
| ILCV · iShares Trust | 0,03% | 2.187 SH | 11. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 15.958 SH | 2. Oktober 2026 | Täglich |
| XRMI · Global X Funds | 0,03% | 74 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,03% | 30.498 NS | 31. Juli 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 42.821 SH | 11. September 2026 | Täglich |
| SPUU · Direxion Shares ETF Trust | 0,03% | 370 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,03% | 5 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,03% | 1.236.184 SH | 11. September 2026 | Täglich |
| ILCB · iShares Trust | 0,03% | 1.913 SH | 11. September 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,03% | 583 SH | 2. Oktober 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,03% | 16.872 SH | 2. Oktober 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,03% | 13.984 SH | 2. Oktober 2026 | Täglich |
| VOO · VANGUARD INDEX FUNDS | 0,03% | 2.548.531 SH | 19. August 2026 | Täglich |
| VV · VANGUARD INDEX FUNDS | 0,03% | 114.510 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,03% | 3.115.102 SH | 19. August 2026 | Täglich |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,03% | 36.417 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,03% | 16.114 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,03% | 8.227 SH | 19. August 2026 | Täglich |
| IYY · iShares Trust | 0,03% | 4.226 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,03% | 67.954 SH | 11. September 2026 | Täglich |
| IVW · iShares Trust | 0,03% | 105.352 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,03% | 128.261 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,03% | 26.980 SH | 11. September 2026 | Täglich |
| XTR · Global X Funds | 0,03% | 6 NS | 31. Juli 2026 | N-PORT |
| ILCG · iShares Trust | 0,03% | 4.117 SH | 10. September 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,03% | 683 NS | 31. Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,03% | 42.749 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,03% | 78 SH | 2. Oktober 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,03% | 7.670 NS | 31. Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,02% | 271 SH | 11. September 2026 | Täglich |
| URTH · iShares, Inc. | 0,02% | 9.040 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 83.634 SH | 19. August 2026 | Täglich |
| ACWI · iShares Trust | 0,02% | 30.640 SH | 11. September 2026 | Täglich |
| PZA · Invesco Exchange-Traded Fund Trust … | 0,02% | 795.000 | 2. Oktober 2026 | Täglich |
| DFVX · Dimensional ETF Trust | 0,00% | 82 NS | 31. Juli 2026 | N-PORT |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14. Juli 2026 | Täglich |
STE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 16 Analysten
KAUF
Median-Ziel
$269.50
+29,2%
3 18,8%
Starker Kauf
8 50,0%
Kauf
5 31,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-10-02Mittelwert-Ziel $263.12 +26,2%
← Unter allen Zielen
Aktueller Preis $208.54
Tief$232.00
Mittelwert$263.12
Hoch$280.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 7, 2026